Stay updated on Pembrolizumab for Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all relate to the study, and updated the page revision to v3.3.2. The corresponding deletions reference PubMed-derived publications and list revision v3.2.0.SummaryDifference0.1%

- Check26 days agoChange DetectedRemoved the government funding status banner that warned about potential data delays and directed users to opm.gov for updates.SummaryDifference0.4%

- Check40 days agoChange DetectedUI/layout updates were applied to the Study Details page with no substantial changes to core study information such as eligibility, enrollment, endpoints, or timelines. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check69 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference3%

- Check76 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check90 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed as a minor UI cleanup.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab for Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.